Increased Myogenic and Protein Turnover Signaling in Skeletal Muscle of Chronic Obstructive Pulmonary Disease Patients With Sarcopenia

Anita E. M. Kneppers, Ramon C. J. Langen, Harry R. Gosker, Lex B. Verdijk, Nanca Cebron Lipovec, Pieter A. Leermakers, Marco C. J. M. Kelders, Chiel C. de Theije, Daniel Omersa, Mitja Lainscak, Annemie M. W. J. Schols*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

411 Downloads (Pure)

Abstract

Background: Sarcopenia was recently recognized as an independent condition by an International Classification of Diseases, Tenth Revision, Clinical Modification code, and is a frequently observed comorbidity in chronic obstructive pulmonary disease (COPD). Muscle mass is primarily dictated by the balance between protein degradation and synthesis, but their relative contribution to sarcopenia is unclear.

Objective: We aimed to assess potential differential molecular regulation of protein degradation and synthesis, as well as myogenesis, in the skeletal muscle of COPD patients with and without sarcopenia.

Methods: Muscle biopsies were obtained from the vastus lateralis muscle. Patients with COPD were clustered based on sarcopenia defined by low appendicular skeletal muscle mass index (nonsarcopenic COPD, n = 53; sarcopenic COPD, n = 39), and compared with healthy nonsarcopenic controls (n = 13). The mRNA and protein expression of regulators and mediators of ubiquitin-proteasome system (UPS), autophagy-lysosome system (autophagy), and protein synthesis were analyzed. Furthermore, mRNA expression of myogenesis markers was assessed.

Results: UPS signaling was unaltered, whereas indices of UPS regulation (eg, FOXO1 protein; p-FOXO3/FOXO3), autophagy signaling (eg, LC3BII/I; p-ULK1[Ser757]/ULK1), and protein synthesis signaling (eg, AKT1; p-GSK3B/GSK3B; p-4E-BP1/4E-BP1) were increased in COPD. These alterations were even more pronounced in COPD patients with sarcopenia (eg, FOXO1 protein; p-FOXO1/FOXO1; LC3BII/I; p-ULK(Ser555); p-AKT1/AKT1; AKT1; p-4E-BP1). Furthermore, myogenic signaling (eg, MYOG) was increased in COPD despite a concomitant increase of myostatin (MSTN) mRNA expression, with no difference between sarcopenic and nonsarcopenic COPD patients.

Conclusion: Together with elevated myogenic signaling, the increase in muscle protein turnover signaling in COPD, which is even more prominent in COPD patients with sarcopenia, reflects molecular alterations associated with muscle repair and remodeling. (C) 2017 AMDA - The Society for Post-Acute and Long-Term Care Medicine.

Original languageEnglish
Pages (from-to)637.e1-637.e11
Number of pages11
JournalJournal of the American Medical Directors Association
Volume18
Issue number7
DOIs
Publication statusPublished - 1 Jul 2017

Keywords

  • Muscular atrophy
  • protein biosynthesis
  • proteolysis
  • myogenic differentiation
  • MYOBLAST DIFFERENTIATION
  • NUTRITIONAL DEPLETION
  • ECCENTRIC EXERCISE
  • OXIDATIVE STRESS
  • SATELLITE CELLS
  • MODERATE COPD
  • QUADRICEPS
  • AUTOPHAGY
  • EXPRESSION
  • ATROPHY

Cite this